Ratiopharm High Resolution Stock Photography and Images - Alamy
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
Giant becomes even bigger: Teva acquires ratiopharm
Teva to buy German generic drug maker Ratiopharm - The San Diego Union-Tribune
Teva: 'Celltrion deal will double biosimilar sales to $600m'
Boxes of medication by German pharmaceuticals company Ratiopharm and... News Photo - Getty Images
Teva with ratiopharm market leader in European generics
Teva and Bristows win obviousness claim against Bayer cancer drug - JUVE Patent
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. reacts during a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625 billion euros.
Oliver Windholz, chairman of Ratiopharm Group, listens during a news... News Photo - Getty Images